...
首页> 外文期刊>Artificial intelligence in medicine >Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach
【24h】

Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach

机译:使用逐步前向选择人工神经网络建模方法鉴定可预测雌激素受体和淋巴结状态的基因转录特征

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: The advent of microarrays has attracted considerable interest from biologists due to the potential for high throughput analysis of hundreds of thousands of gene transcripts. Subsequent analysis of the data may identify specific features which correspond to characteristics of interest within the population, for example, analysis of gene expression profiles in cancer patients to identify molecular signatures corresponding with prognostic outcome. These high throughput technologies have resulted in an unprecedented rate of data generation, often of high complexity, highlighting the need for novel data analysis methodologies that will cope with data of this nature. Methods: Stepwise methods using artificial neural networks (ANNs) have been developed to identify an optimal subset of predictive gene transcripts from highly dimensional microarray data. Here these methods have been applied to a gene microarray dataset to identify and validate gene signatures corresponding with estrogen receptor and lymph node status in breast cancer. Results: Many gene transcripts were identified whose expression could differentiate patients to very high accuracies based upon firstly whether they were positive or negative for estrogen receptor, and secondly whether metastasis to the axillary lymph node had occurred. A number of these genes had been previously reported to have a role in cancer. Significantly fewer genes were used compared to other previous studies. The models using the optimal gene subsets were internally validated using an extensive random sample cross-validation procedure and externally validated using a follow up dataset from a different cohort of patients on a newer array chip containing the same and additional probe sets. Here, the models retained high accuracies, emphasising the potential power of this approach in analysing complex systems. These findings show how the proposed method allows for the rapid analysis and subsequent detailed interrogation of gene expression signatures to provide a further understanding of the underlying molecular mechanisms that could be important in determining novel prognostic markers associated with cancer.
机译:目的:由于高通量分析潜在的成千上万的基因转录本,微阵列的出现引起了生物学家的极大兴趣。数据的后续分析可以识别与人群中感兴趣的特征相对应的特定特征,例如,分析癌症患者中的基因表达谱以识别与预后相对应的分子标志。这些高吞吐率技术导致空前的数据生成速度,通常具有很高的复杂性,这凸显了需要新颖的数据分析方法来处理这种性质的数据的需求。方法:已开发出使用人工神经网络(ANN)的逐步方法,以从高维微阵列数据中识别预测基因转录本的最佳子集。在这里,这些方法已应用于基因微阵列数据集,以识别和验证与乳腺癌中雌激素受体和淋巴结状态相对应的基因标记。结果:首先,根据其雌激素受体阳性或阴性,其次是否发生转移至腋窝淋巴结,鉴定出许多基因表达,其表达可将患者区分为非常高的准确性。先前已经报道了许多这些基因在癌症中起作用。与其他先前的研究相比,使用的基因明显更少。使用广泛的随机样本交叉验证程序对使用最佳基因子集的模型进行内部验证,并使用包含相同和其他探针组的新型阵列芯片上来自不同队列的患者的随访数据集对内部进行验证。在这里,模型保留了较高的准确性,强调了这种方法在分析复杂系统中的潜在能力。这些发现表明,所提出的方法如何允许对基因表达特征进行快速分析和随后的详细询问,以提供对潜在分子机制的进一步理解,这些分子机制对于确定与癌症相关的新的预后标记可能很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号